What Would a Donanemab Approval Mean for Leqembi?
Earlier this month, an FDA advisory committee determined that Eli Lilly’s anti-amyloid antibody donanemab is an effective treatment for Alzheimer’s disease and that its…
Empowering Your Journey to a Healthier You
Wellness Accelerator
